3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
53
Neoplasms
36
Lung Neoplasms
25
Colorectal Neoplasms
23
Prostatic Neoplasms
17
Uterine Cervical Neoplasms
14
Motor Activity
13
Colonic Neoplasms
11
Carcinoma, Non-Small-Cell Lung
10
Rectal Neoplasms
9
Anxiety Disorders
9
Urinary Bladder Neoplasms
8
Pancreatic Neoplasms
8
Obesity
8
Melanoma
8
Depression
8
Lymphoma
7
Hematologic Neoplasms
7
Endometrial Neoplasms
7
Vulvar Neoplasms
6
Ovarian Neoplasms
6
Head and Neck Neoplasms
6
Breast Carcinoma In Situ
6
Sarcoma
5
Pain
5
Hematopoietic and Lymphatic System Neoplasm
5
Triple Negative Breast Neoplasms
4
Stomach Neoplasms
4
Papillomavirus Infections
4
Neoplasm Metastasis
4
Interventions
Tenofovir
4
peginterferon alfa-2b
2
entecavir
2
peginterferon alfa-2a
1
ibrutinib
1
durvalumab
1
babao dan
1
Radiofrequency Ablation
1
Observation
1
Nucleosides
1
Methods
1
Interferons
1
Cholecalciferol
1
Acids
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Hepatitis B, Chronic
×
Methods
×
Clear all
NCT07120750
2025-08-13
PRTRAS 001
Shenzhen Third People's Hospital
Not yet recruiting
332 enrolled